Article | October 5, 2023

Cell And Gene Therapy: 2023 And Beyond

Source: AST

By James Calle

AST- Stäubli TX2 series Stericlean robot

The potential of cell and gene therapies is clear, and the groundbreaking wave of treatments is only expected to keep building. But with a maturing market comes challenges. Regulations around cell and gene therapy are progressing as well, and though governing bodies are making attempts to optimize regulatory standards around the rapidly evolving nature of cell and gene therapy production, there are still hurdles to clear. These stringent quality standards point to some necessary differentiators for any successful cell and gene manufacturing operation. Explore best aseptic practices for cell and gene therapy production that will be foundational to their ongoing development.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online